GraniteShares Bloomberg Commodity Broad Strategy No K-1 ETF COMB 深 沪
已收盘 09-19 16:00:00 美东时间
21.42
-0.060
-0.28%
华盛通- 最 高21.45
- 今 开21.3751
- 成交量 9927股
- 最 低 21.36
- 昨 收 21.48
- 总市值 7925.40万
- 52周最高 22.04
- 市盈率 静 --
- 换手率 0.27%
- 52周最低 19.2262
- 委 比 0.00%
- 总股本 370.00万
- 历史最高 27.097
- 量 比 0.60
- 振 幅 0.42%
- 历史最低 4.4999
- 每 手 1
- 风险率 0.69%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MediciNova Issues Shareholder Update; Secures $30M SEPA To Advance R&D As COMBAT-ALS Trial Hits Enrollment Target; NIH-Funded EAP And MN-001 Diabetes Study Near Completion
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the "Company"), provides a shareholder
09-08 21:12
Club Offers Released on June 19, 2025
TORONTO, June 19, 2025 /PRNewswire/ -- Travelzoo® (NASDAQ: TZOO), the club for travel enthusiasts, announces the release of Club Offers for Club Members. Rigorously vetted and negotiated for...
06-19 20:02
币安决定于2025年3月28日11:00停止交易并下架AERGO、AST等币种
博链财经BroadChain获悉，币安决定于2025年3月28日11：00停止交易并下架以下币种：Aergo（AERGO）、AirSwap（AST）、Bu...
03-21 17:32
AI味儿最浓的一届AWE，家电厂商都有哪些花活儿？
作者丨习翔宇 编辑丨苏建勋 邱晓芬 3月14日，AWE2024（中国家电及消费电子博览会）在上海新国际博览中心开幕。36氪连逛两天，走遍全场13个展馆，发现今年...
2024-03-16 11:09
Hikma announces US launch of COMBOGESIC® IV
Offers health care providers a new multimodal approach to adult pain management LONDON, Feb. 5, 2024 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical compa...
2024-02-05 20:00
Jaypirca® (pirtobrutinib) Now Approved by U.S. FDA for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Received at Least Two Lines of Therapy, Including a BTK Inhibitor and a BCL-2 Inhibitor
The first and only non-covalent (reversible) BTK inhibitor, Jaypirca has been shown to extend the benefit of BTK inhibition In the BRUIN Phase 1/2 trial, adult patients with CLL/SLL who have...
2023-12-02 06:22
GIANT BIOGENE(2367.HK):PIONEER IN RECOMBINANT COLLAGEN MARKET
Giant Biogene is a leader in the professional skin treatment industry in China,...
2023-11-27 14:42
心血管介入治疗先行者，未来发展前景亮丽，业聚医疗（6929.HK）藉上市爆发潜力
心血管疾病是全球头号杀手，严重威胁人们健康，尤其常见于50岁以上人仕身上。随着全球人口老龄化问题加剧，心血管疾病的患病率呈逐年升高趋势，如何针对心血管疾病去进行...
2022-12-13 09:22
血管介入器械出海之光！冲刺IPO的业聚医疗如何实现国产逆袭？
我国血管介入高值耗材产业发展超过二十年，球囊这一重要单品一直是难越的关山。 在PCI（经皮冠状动脉介入治疗）球囊市场，超过70%的市场仍然由雅培、波士顿科学、美...
2022-08-08 08:00
